Boston Partners Has $13.86 Million Stake in Universal Health Services, Inc. $UHS

Boston Partners boosted its holdings in Universal Health Services, Inc. (NYSE:UHS) by 112.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 76,511 shares of the health services provider’s stock after buying an additional 40,457 shares during the quarter. Boston Partners owned approximately 0.12% of Universal Health Services worth $13,858,000 at the end of the most recent reporting period.

Several other hedge funds have also recently added to or reduced their stakes in the company. Invesco Ltd. grew its position in shares of Universal Health Services by 6.0% during the 1st quarter. Invesco Ltd. now owns 1,315,468 shares of the health services provider’s stock worth $247,176,000 after buying an additional 74,128 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Universal Health Services by 9.0% during the first quarter. Dimensional Fund Advisors LP now owns 1,241,738 shares of the health services provider’s stock worth $233,311,000 after purchasing an additional 102,137 shares during the last quarter. AQR Capital Management LLC boosted its position in Universal Health Services by 57.8% in the first quarter. AQR Capital Management LLC now owns 931,355 shares of the health services provider’s stock worth $173,381,000 after purchasing an additional 340,966 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in Universal Health Services by 3.5% in the second quarter. Massachusetts Financial Services Co. MA now owns 926,669 shares of the health services provider’s stock valued at $167,866,000 after acquiring an additional 31,201 shares during the last quarter. Finally, American Century Companies Inc. raised its stake in shares of Universal Health Services by 0.8% in the second quarter. American Century Companies Inc. now owns 639,524 shares of the health services provider’s stock valued at $115,850,000 after buying an additional 4,932 shares during the period. Institutional investors own 86.05% of the company’s stock.

Insider Activity

In other Universal Health Services news, Director Warren J. Nimetz sold 3,817 shares of the business’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $223.30, for a total value of $852,336.10. Following the completion of the sale, the director directly owned 8,481 shares of the company’s stock, valued at $1,893,807.30. The trade was a 31.04% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Elliot J. Md Mba Sussman sold 965 shares of Universal Health Services stock in a transaction dated Wednesday, October 29th. The shares were sold at an average price of $225.70, for a total value of $217,800.50. Following the completion of the sale, the director owned 6,113 shares of the company’s stock, valued at $1,379,704.10. The trade was a 13.63% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 16.40% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research firms have issued reports on UHS. Royal Bank Of Canada restated a “sector perform” rating on shares of Universal Health Services in a research report on Thursday, October 30th. JPMorgan Chase & Co. reduced their price objective on shares of Universal Health Services from $215.00 to $195.00 and set a “neutral” rating on the stock in a research report on Monday, August 4th. Mizuho set a $242.00 target price on shares of Universal Health Services in a research report on Tuesday, October 28th. Morgan Stanley set a $233.00 price target on shares of Universal Health Services in a research note on Wednesday, October 29th. Finally, UBS Group set a $231.00 target price on Universal Health Services in a research report on Thursday, October 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $232.64.

Universal Health Services Trading Down 0.7%

UHS stock opened at $242.54 on Friday. The company has a market capitalization of $15.15 billion, a price-to-earnings ratio of 11.52, a PEG ratio of 0.80 and a beta of 1.33. Universal Health Services, Inc. has a 1-year low of $152.33 and a 1-year high of $246.32. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.03 and a quick ratio of 1.19. The business has a 50 day simple moving average of $215.79 and a two-hundred day simple moving average of $192.44.

Universal Health Services (NYSE:UHS) last issued its quarterly earnings data on Tuesday, October 28th. The health services provider reported $5.69 earnings per share for the quarter, beating analysts’ consensus estimates of $4.66 by $1.03. The firm had revenue of $4.50 billion during the quarter, compared to analyst estimates of $4.32 billion. Universal Health Services had a return on equity of 19.47% and a net margin of 8.09%.The business’s quarterly revenue was up 13.4% compared to the same quarter last year. During the same quarter last year, the business posted $3.71 earnings per share. Research analysts anticipate that Universal Health Services, Inc. will post 15.92 EPS for the current fiscal year.

Universal Health Services Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 15th. Stockholders of record on Monday, December 1st will be paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Monday, December 1st. Universal Health Services’s dividend payout ratio (DPR) is presently 3.80%.

Universal Health Services Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.